Pharmacodynamic assessments were defined according to P@Y@ reaction unit ( PRU ) ( P@Y@ assay ) and platelet reactivity index ( vasodilator-stimulated phosphoprotein phosphorylation assay ) at baseline ( before and after the run-in phase ) and @ , @ , @ , and @ h and @ days after randomization .